---
layout: minimal-medicine
nav_exclude: true
title: Glibenclamide + Metformin + Rosiglitazone
---

# Glibenclamide + Metformin + Rosiglitazone

It's crucial to understand that **a single combination pill containing Glibenclamide, Metformin, and Rosiglitazone is not currently available commercially.**  These three drugs are often prescribed together for type 2 diabetes, but separately.  Combining them would require careful individual dose adjustment by a physician due to the risk of significant interactions and side effects.  This information is for educational purposes only and should not be interpreted as a recommendation for self-medication. Always consult with a healthcare professional before starting or changing any medication.


Therefore, providing details in the requested format for a non-existent combined drug is impossible. However, we can provide information on each drug individually and highlight potential interactions if used together:


**Glibenclamide:**

* **Generic Name:** Glibenclamide (also known as Glyburide in the US)
* **Usage:** Treats type 2 diabetes by stimulating the pancreas to release more insulin.
* **Side Effects:** Hypoglycemia (low blood sugar), weight gain, nausea, vomiting, diarrhea, allergic reactions.
* **How it Works:**  It acts on the beta cells of the pancreas, increasing insulin secretion.


**Metformin:**

* **Generic Name:** Metformin
* **Usage:** Treats type 2 diabetes by reducing glucose production by the liver and improving insulin sensitivity.
* **Side Effects:** Gastrointestinal upset (nausea, diarrhea, vomiting), lactic acidosis (rare but serious), vitamin B12 deficiency.
* **How it Works:** It primarily works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues.


**Rosiglitazone:**

* **Generic Name:** Rosiglitazone
* **Usage:** Treats type 2 diabetes by improving insulin sensitivity in the body's tissues.
* **Side Effects:** Fluid retention, weight gain, increased risk of heart failure, bone fractures, bladder cancer (potential increased risk).  Note: Rosiglitazone's use is restricted in many countries due to safety concerns.
* **How it Works:** It acts as a PPAR-gamma agonist, increasing insulin sensitivity in muscle, liver, and adipose tissue.


**Potential Interactions and Concerns if used together (Glibenclamide + Metformin + Rosiglitazone):**

* **Increased risk of hypoglycemia:** Glibenclamide and Rosiglitazone can both lead to hypoglycemia, and combining them with Metformin (which can sometimes cause hypoglycemia) significantly increases this risk.
* **Weight gain:** Both Glibenclamide and Rosiglitazone can cause weight gain, exacerbating the problem.
* **Cardiovascular risks:** Rosiglitazone has known cardiovascular risks, and combining it with other medications carries added risk.
* **Lactic acidosis:** The risk of lactic acidosis associated with Metformin is slightly increased when combined with other diabetes medications.


**FAQs (Regarding individual drugs and their potential combined use):**

* **Q: Can I take these three drugs together?** A: No, you should not take these three drugs together without direct supervision and careful monitoring by a physician.  The risk of serious side effects is significantly increased.
* **Q: What are the alternatives?** A:  Many other diabetes medications are available, alone or in combination, that offer better safety profiles than this particular combination. Your doctor can determine the best treatment plan for you.
*

**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.